NCT00003600 - Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | Biotech Hunter

Enrollment

344

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

December 31, 2001

Study Completion Date

January 31, 2010

Conditions

AnemiaBreast CancerChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemiaLung CancerLymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

epoetin alfa

OTHER

placebo

Trial Locations (21)

20060

Howard University Cancer Center, Washington D.C.

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

70121

CCOP - Ochsner, New Orleans

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER